Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus.

Odqvist L, Jevnikar Z, Riise R, Öberg L, Rhedin M, Leonard D, Yrlid L, Jackson S, Mattsson J, Nanda S, Cohen P, Knebel A, Arthur S, Thörn K, Svenungsson E, Jönsen A, Gunnarsson I, Tandre K, Alexsson A, Kastbom A, Rantapää-Dahlqvist S, Eloranta ML, Syvänen AC, Bengtsson A, Johansson P, Sandling JK, Sjöwall C, Rönnblom L, Collins B, Vaarala O.

Ann Rheum Dis. 2019 Oct;78(10):1363-1370. doi: 10.1136/annrheumdis-2019-215434. Epub 2019 Jul 12.

2.

IL-17-high asthma with features of a psoriasis immunophenotype.

Östling J, van Geest M, Schofield JPR, Jevnikar Z, Wilson S, Ward J, Lutter R, Shaw DE, Bakke PS, Caruso M, Dahlen SE, Fowler SJ, Horváth I, Krug N, Montuschi P, Sanak M, Sandström T, Sun K, Pandis I, Auffray C, Sousa AR, Guo Y, Adcock IM, Howarth P, Chung KF, Bigler J, Sterk PJ, Skipp PJ, Djukanović R, Vaarala O; U-BIOPRED Study Group.

J Allergy Clin Immunol. 2019 Nov;144(5):1198-1213. doi: 10.1016/j.jaci.2019.03.027. Epub 2019 Apr 15.

PMID:
30998987
3.

Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation.

Jevnikar Z, Östling J, Ax E, Calvén J, Thörn K, Israelsson E, Öberg L, Singhania A, Lau LCK, Wilson SJ, Ward JA, Chauhan A, Sousa AR, De Meulder B, Loza MJ, Baribaud F, Sterk PJ, Chung KF, Sun K, Guo Y, Adcock IM, Payne D, Dahlen B, Chanez P, Shaw DE, Krug N, Hohlfeld JM, Sandström T, Djukanovic R, James A, Hinks TSC, Howarth PH, Vaarala O, van Geest M, Olsson H; Unbiased Biomarkers in Prediction of Respiratory Disease Outcomes study group.

J Allergy Clin Immunol. 2019 Feb;143(2):577-590. doi: 10.1016/j.jaci.2018.05.026. Epub 2018 Jun 11.

4.

CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas.

Juilland M, Gonzalez M, Erdmann T, Banz Y, Jevnikar Z, Hailfinger S, Tzankov A, Grau M, Lenz G, Novak U, Thome M.

Blood. 2016 Apr 7;127(14):1780-9. doi: 10.1182/blood-2015-07-655647. Epub 2016 Jan 8.

5.

Cathepsin S generates soluble CX3CL1 (fractalkine) in vascular smooth muscle cells.

Fonović UP, Jevnikar Z, Kos J.

Biol Chem. 2013 Oct;394(10):1349-52. doi: 10.1515/hsz-2013-0189.

PMID:
23893684
6.

Profilin 1 as a target for cathepsin X activity in tumor cells.

Pečar Fonović U, Jevnikar Z, Rojnik M, Doljak B, Fonović M, Jamnik P, Kos J.

PLoS One. 2013;8(1):e53918. doi: 10.1371/journal.pone.0053918. Epub 2013 Jan 10.

7.

Iron-regulated surface determinant B (IsdB) promotes Staphylococcus aureus adherence to and internalization by non-phagocytic human cells.

Zapotoczna M, Jevnikar Z, Miajlovic H, Kos J, Foster TJ.

Cell Microbiol. 2013 Jun;15(6):1026-41. doi: 10.1111/cmi.12097. Epub 2013 Jan 15.

PMID:
23279065
8.

Cathepsin H mediates the processing of talin and regulates migration of prostate cancer cells.

Jevnikar Z, Rojnik M, Jamnik P, Doljak B, Fonovic UP, Kos J.

J Biol Chem. 2013 Jan 25;288(4):2201-9. doi: 10.1074/jbc.M112.436394. Epub 2012 Nov 30.

9.

Three-dimensional invasion of macrophages is mediated by cysteine cathepsins in protrusive podosomes.

Jevnikar Z, Mirković B, Fonović UP, Zidar N, Švajger U, Kos J.

Eur J Immunol. 2012 Dec;42(12):3429-41. doi: 10.1002/eji.201242610. Epub 2012 Nov 7.

10.

Cathepsin H indirectly regulates morphogenetic protein-4 (BMP-4) in various human cell lines.

Rojnik M, Jevnikar Z, Mirkovic B, Janes D, Zidar N, Kikelj D, Kos J.

Radiol Oncol. 2011 Dec;45(4):259-66. doi: 10.2478/v10019-011-0034-3. Epub 2011 Oct 8.

11.

The influence of differential processing of procathepsin H on its aminopeptidase activity, secretion and subcellular localization in human cell lines.

Rojnik M, Jevnikar ZR, Doljak B, Turk S, Zidar N, Kos J.

Eur J Cell Biol. 2012 Oct;91(10):757-64. doi: 10.1016/j.ejcb.2012.05.004. Epub 2012 Jun 14.

PMID:
22704610
12.

LFA-1 fine-tuning by cathepsin X.

Jevnikar Z, Obermajer N, Kos J.

IUBMB Life. 2011 Sep;63(9):686-93. doi: 10.1002/iub.505. Epub 2011 Jul 27. Review.

13.

Novel mechanism of cathepsin B inhibition by antibiotic nitroxoline and related compounds.

Mirković B, Renko M, Turk S, Sosič I, Jevnikar Z, Obermajer N, Turk D, Gobec S, Kos J.

ChemMedChem. 2011 Aug 1;6(8):1351-6. doi: 10.1002/cmdc.201100098. Epub 2011 May 20. No abstract available.

PMID:
21598397
14.

Cathepsin X cleavage of the beta2 integrin regulates talin-binding and LFA-1 affinity in T cells.

Jevnikar Z, Obermajer N, Doljak B, Turk S, Gobec S, Svajger U, Hailfinger S, Thome M, Kos J.

J Leukoc Biol. 2011 Jul;90(1):99-109. doi: 10.1189/jlb.1110622. Epub 2011 Mar 31.

PMID:
21454358
15.

Identification of candidate carrier proteins for surface display on Lactococcus lactis by theoretical and experimental analyses of the surface proteome.

Berlec A, Zadravec P, Jevnikar Z, Štrukelj B.

Appl Environ Microbiol. 2011 Feb;77(4):1292-300. doi: 10.1128/AEM.02102-10. Epub 2010 Dec 23.

16.

Cathepsin X cleaves the beta2 cytoplasmic tail of LFA-1 inducing the intermediate affinity form of LFA-1 and alpha-actinin-1 binding.

Jevnikar Z, Obermajer N, Pecar-Fonović U, Karaoglanovic-Carmona A, Kos J.

Eur J Immunol. 2009 Nov;39(11):3217-27. doi: 10.1002/eji.200939562.

17.

Cysteine protease-mediated cytoskeleton interactions with LFA-1 promote T-cell morphological changes.

Jevnikar Z, Obermajer N, Kos J.

Cell Motil Cytoskeleton. 2009 Nov;66(11):1030-40. doi: 10.1002/cm.20413.

PMID:
19670215
18.

Regulation of cathepsin B activity by 2A2 monoclonal antibody.

Mirković B, Premzl A, Hodnik V, Doljak B, Jevnikar Z, Anderluh G, Kos J.

FEBS J. 2009 Sep;276(17):4739-51. doi: 10.1111/j.1742-4658.2009.07171.x. Epub 2009 Jul 27.

19.

The role of cathepsin X in cell signaling.

Kos J, Jevnikar Z, Obermajer N.

Cell Adh Migr. 2009 Apr-Jun;3(2):164-6. Epub 2009 Apr 13. Review.

20.

Cathepsin X-mediated beta2 integrin activation results in nanotube outgrowth.

Obermajer N, Jevnikar Z, Doljak B, Sadaghiani AM, Bogyo M, Kos J.

Cell Mol Life Sci. 2009 Mar;66(6):1126-34. doi: 10.1007/s00018-009-8829-8.

PMID:
19194656
21.

The role of cathepsin X in the migration and invasiveness of T lymphocytes.

Jevnikar Z, Obermajer N, Bogyo M, Kos J.

J Cell Sci. 2008 Aug 15;121(Pt 16):2652-61. doi: 10.1242/jcs.023721. Epub 2008 Jul 29.

22.

Role of cysteine cathepsins in matrix degradation and cell signalling.

Obermajer N, Jevnikar Z, Doljak B, Kos J.

Connect Tissue Res. 2008;49(3):193-6. doi: 10.1080/03008200802143158. Review.

PMID:
18661341
23.

Cysteine protease cathepsin X modulates immune response via activation of beta2 integrins.

Obermajer N, Repnik U, Jevnikar Z, Turk B, Kreft M, Kos J.

Immunology. 2008 May;124(1):76-88. doi: 10.1111/j.1365-2567.2007.02740.x. Epub 2008 Jan 11.

24.

Expression of the sweet-tasting plant protein brazzein in Escherichia coli and Lactococcus lactis: a path toward sweet lactic acid bacteria.

Berlec A, Jevnikar Z, Majhenic AC, Rogelj I, Strukelj B.

Appl Microbiol Biotechnol. 2006 Nov;73(1):158-65. Epub 2006 May 16.

PMID:
16703320

Supplemental Content

Loading ...
Support Center